Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Gains from Investment Securities: 2021-2024

Historic Gains from Investment Securities for P3 Health Partners (PIII) over the last 4 years, with FY2024 value amounting to -$22.1 million.

  • P3 Health Partners' Gains from Investment Securities rose 14427.4% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.9 million, marking a year-over-year increase of 15528.56%. This contributed to the annual value of -$22.1 million for FY2024, which is 40620.33% down from last year.
  • Per P3 Health Partners' latest filing, its Gains from Investment Securities stood at -$22.1 million for FY2024, which was down 40620.33% from $7.2 million recorded in FY2023.
  • P3 Health Partners' Gains from Investment Securities' 5-year high stood at $7.7 million during FY2021, with a 5-year trough of -$22.1 million in FY2024.
  • In the last 4 years, P3 Health Partners' Gains from Investment Securities had a median value of -$1.3 million in 2022 and averaged -$4.3 million.
  • In the last 5 years, P3 Health Partners' Gains from Investment Securities skyrocketed by 17320.83% in 2023 and then crashed by 40620.33% in 2024.
  • Over the past 4 years, P3 Health Partners' Gains from Investment Securities (Annual) stood at $7.7 million in 2021, then tumbled by 228.7% to -$9.9 million in 2022, then soared by 173.21% to $7.2 million in 2023, then plummeted by 406.2% to -$22.1 million in 2024.
  • Its Gains from Investment Securities was -$22.1 million in FY2024, compared to $7.2 million in FY2023 and -$9.9 million in FY2022.